Roles of Sodium-Glucose Cotransporter 2 of Mesangial Cells in Diabetic Kidney Disease

We have been studying the presence of sodium-glucose cotransporter 2 (SGLT2) in mesangial cells and pericytes since 1992. Recent large placebo-controlled studies of SGLT2 inhibitors in patients with type 2 diabetes mellitus have reported desirable effects of the inhibitors on the diabetic kidney and...

Descripción completa

Detalles Bibliográficos
Autores principales: Wakisaka, Masanori, Nakamura, Kuniyuki, Nakano, Toshiaki, Kitazono, Takanari
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2021
Materias:
Mini-Reviews
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8237847/
https://www.ncbi.nlm.nih.gov/pubmed/34195526
http://dx.doi.org/10.1210/jendso/bvab083

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8237847/
https://www.ncbi.nlm.nih.gov/pubmed/34195526
http://dx.doi.org/10.1210/jendso/bvab083

Ejemplares similares